MASP2 and rheumatic heart disease: The authors found that low MASP-2 producing variants were associated with protection against the development of RHD and haplotypes sharing intron 9 – exon 12 polymorphisms increased the susceptibility to RHD, when compared to RF patients without cardiac disease.